The Mounjaro Cost Increase: What UK Patients Are Actually Paying Now

Step 1: Understand what changed and why the numbers vary so widely

Eli Lilly announced a UK list-price revision that took effect on 1 September 2025. Before that date, a single Mounjaro KwikPen (which contains four weekly doses) listed at around £122 regardless of strength. After the revision, higher doses attracted substantially higher list prices, with the 15mg pen widely reported at around £330. Lower strengths saw smaller increases. If you want a detailed breakdown of what shifted and by how much, the Mounjaro price increase page sets out the full picture of the revision across all dose strengths. These figures are list prices: what individual private providers actually charge reflects their own margins, the services bundled in, and their cost of sourcing through the licensed UK supply chain.

That spread (roughly £149 to £375 per month across the market) is real, and it is wide. Part of the explanation is dose: a patient on 2.5mg pays less than one on 10mg. Part of it is what the price includes. And part of it is simply that providers set different margins. If you want to understand the numbers in more detail, the reasons behind the Mounjaro price increase are worth reading before you make any decisions.

Step 2: Read the small print before you compare headline figures

A headline monthly price is not always the total cost. Across the private market, some providers charge separately for the initial consultation, for the prescription itself, for delivery, or for aftercare calls. A quoted price of £149 that excludes a £30 consultation fee and a £10 delivery charge is not £149. That is worth stating plainly because it catches people out, especially at a time when the Mounjaro cost increase in the UK has made patients particularly price-sensitive.

The pen itself needs refrigeration between 2°C and 8°C (most people keep it in the fridge door) which makes the logistics of delivery matter too. A next-working-day tracked service is meaningfully different from a courier that leaves the box on a doorstep in August. The full picture of how Mounjaro is priced in private practice covers what a legitimate all-in price should look like. Checking the GPhC register at registration number 9012878 confirms that a pharmacy is operating legally before you share your details or make any payment.

Step 3: Know what our position is, and why

At nume, we are not competing to be the cheapest option on a price-comparison table. One transparent price covers the consultation, the clinical review by a GPhC-registered prescriber, the prescription, the medicine and free next-working-day tracked delivery by DPD in plain packaging. There are no add-ons. That approach costs more than providers who strip those elements out and sell them separately, and it costs more than those who skip parts of the clinical assessment entirely.

Our prescribers review every consultation personally, the same day. No algorithm makes the call. Before every repeat order, the prescription is reviewed again, so dose changes, new symptoms and changes in your health are not missed. If you want to understand the current price for the specific dose or treatment you are considering, your free consultation is the right place to start. Our clinical team is introduced on the clinical team page if you want to know who reviews your notes.

Step 4: Ask the right question about cost

After a significant price increase, it is natural to shop around. The question is what you are shopping for. Mounjaro is a prescription-only medicine. The MHRA has publicly warned about counterfeit weight-loss pens sold through unverified channels, some of which have been found to contain insulin rather than tirzepatide. Around twenty million doses of illegally traded weight-loss medicines were seized in the UK in 2025 alone. Sellers offering these medicines without a prescription, or at prices far below the market range above, are significant red flags. Report anything suspicious via the MHRA Yellow Card scheme.

A modest saving on one pen is not worth the risk of receiving a counterfeit product, having no clinical oversight, or missing a contraindication that a prescriber would have caught. The NICE appraisal for tirzepatide (TA1026) exists precisely because this medicine works, when used clinically, in the right patient, at the right dose. Price matters. Clinical safety matters more. Those two things are not in conflict when a provider is doing both properly. Explore the detail of making Mounjaro work within your budget for practical guidance on that balance, or check the dose tiers where list prices changed least if you are trying to understand your options by strength.